Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
M4OC-Prevent 2.0: Metformin for Oral Cancer Prevention
NCT05237960Phase 2Active, not recruiting
- Sponsor
- University of Arizona
- Start
- Jan 2023
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in oral leukoplakia, erythroplakia, sponsored by University of Arizona. Started Jan 2023; status: active, not recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
oral leukoplakiaerythroplakia
Beyond the preview
Go deeper on NCT05237960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05237960.